News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News RentRedi Launches “Late Rent Report” to Help Landlords Track and Collect Rent Faster News DeepL’s Language AI services now available through the Digital Vending Machine® from Bango News Syncron Accelerates North American Expansion to Meet Rising Aftermarket Solution Demand News Scrum Alliance and Northwestern University Launch New Change Management Course News Solo.io Brings Agent Skills to the Kubernetes Ecosystem News Elastic Path Expands Intelligent Commerce Platform with Native Search, CMS, and Frontend Hosting